Log In
Or create an account ->
Imperial Library
Home
About
News
Upload
Forum
Help
Login/SignUp
Index
Cover
Title Page
Copyright
Contents
Foreword by Arthur Caplan
Introduction
Chapter 1: “The Corporate Capture of Academic Science and Its Social Costs,”
Chapter 2: “Academic-Corporate Ties in Biotechnology: A Quantitative Study,”
Chapter 3: “Science, Society, and the Expanding Boundaries of Moral Discourse,”
Chapter 4: “Financial Interest of Authors in Scientific Journals: A Pilot Study of 14 Publications,”
Chapter 5: “Financial Interest and Its Disclosure in Scientific Publications,”
Chapter 6: “The Profit of Scientific Discovery and Its Normative Implications,”
Chapter 7: “Conflict of Interest and Cost-Effectiveness Analysis,”
Chapter 8: “Conflict of Interest Policies in Science and Medical Journals: Editorial Practices and Author Disclosures,”
Chapter 9: “Autonomy, Disinterest, and Entrepreneurial Science,”
Chapter 10: “Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry,”
Chapter 11: “The Ethical and Legal Foundations of Scientific ‘Conflict of Interest’,”
Chapter 12: “When Sponsored Research Fails the Admissions Test: A Normative Framework,”
Chapter 13: “Conflicts of Interest and Disclosure in the American Psychiatric Association’s Clinical Practice Guidelines,”
Chapter 14: “Science in the Sunshine: Transparency of Financial Conflicts of Interest,”
Chapter 15: “Combating the Funding Effect in Science: What’s Beyond Transparency?”
Chapter 16: “Beware of Gifts That Come at Too Great a Cost: Danger Lurks for State Universities When Philanthropy Encroaches on Academic Independence,”
Chapter 17: “Do Financial Conflicts of Interest Bias Research? An Inquiry into the ‘Funding Effect’ Hypothesis,”
Chapter 18: “A Comparison of DSM-IV and DSM-5 Panel Members’ Financial Associations with Industry: A Pernicious Problem Persists,”
Chapter 19: “Tripartite Conflicts of Interest and High Stakes Patent Extensions in the DSM-5,”
Chapter 20: “Conflicts of Interest among Committee Members in the National Academies’ Genetically Engineered Crop Study,”
Chapter 21: “Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression,”
Afterword
Notes
Index
← Prev
Back
Next →
← Prev
Back
Next →